Fundraising Fox
/Investor DB
Sign in

VenturEast — 2014 Investments

1 investments dated 2014 · listed companies and verified rows first · show all

Diabetomicsdiabetomics.comOct 2014

ModalityDx develops quantitative point-of-care diagnostic tests using molecular biomarkers and data science to detect and assess treatment response for diseases including diabetes, maternal health conditions, and autoimmune disorders.

BiotechDigital HealthHealthtechMedical DevicesHillsboro, US

Srinivasa Rao Nagalla(Executive Officer, Director, Promoter)Dave Gunderson(Executive Officer, Director)

BoardRick Miller(Director)Chris Dudley(Director)Robert Gregg(Director)Robert Gootee(Director)

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.